[HTML][HTML] Validation study of the Japanese version of the King's Parkinson's Disease Pain Scale and the King's Parkinson's Disease Pain Questionnaire
K Kurihara, S Fujioka, Y Mizutani, H Watanabe… - Parkinsonism & related …, 2024 - Elsevier
Abstract Introduction The King's Parkinson's Disease Pain Scale (KPPS)/King's Parkinson's
Disease Pain Questionnaire (KPPQ) was developed as a tool to quantitatively assess pain …
Disease Pain Questionnaire (KPPQ) was developed as a tool to quantitatively assess pain …
Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label …
J Kassubek, SA Factor, E Balaguer, J Schwarz… - Journal of …, 2024 - Springer
Background Apomorphine sublingual film (SL-APO) is an on-demand treatment for OFF
episodes in patients with Parkinson's disease (PD). Objective To assess the long-term (≥ 3 …
episodes in patients with Parkinson's disease (PD). Objective To assess the long-term (≥ 3 …
Identifying Parkinson's Patients by a Functional Gradient Boosting Approach
Over 10 million people worldwide suffer with Parkinson's disease (PD). The ecumenical
medical community continues to rely on physical examination, scales, signs, and symptoms …
medical community continues to rely on physical examination, scales, signs, and symptoms …
An Overview of a Stepped-care Approach to Modern Holistic and Subtype-driven Care for Parkinson's Disease in the Clinic.
K Popławska-Domaszewicz… - touchREVIEWS in …, 2024 - search.ebscohost.com
Parkinson's disease (PD) is not a single disease, and is characterized by a constellation of
motor and non-motor symptoms (NMS) with a heterogeneity of pathology, genetic basis and …
motor and non-motor symptoms (NMS) with a heterogeneity of pathology, genetic basis and …
[PDF][PDF] NeuroPharmac Journal
Y Jamal, FM Al-Khodairy - 2021 - neuropharmac.com
Parkinson's Disease (PD) is a prevalent movement disorder among the population with
more than 10 million living with PD worldwide. L-DOPA has been a drug of choice in the …
more than 10 million living with PD worldwide. L-DOPA has been a drug of choice in the …
[HTML][HTML] Potential use of neuroprotective and L-DOPA-rich plants in Parkinsonian therapy
Parkinson's Disease (PD) is a prevalent movement disorder among the population with
more than 10 million living with PD worldwide. L-DOPA has been a drug of choice in the …
more than 10 million living with PD worldwide. L-DOPA has been a drug of choice in the …